Intergene Biosciences

Bengaluru, India Founded: 2021 • Age: 5 yrs
Provides genetic sequencing, analysis, and RD support for life sciences professionals.

About Intergene Biosciences

Intergene Biosciences is a Healthcare company based in Bengaluru (India) founded in 2021. It provides genetic sequencing, analysis, and RD support for life sciences professionals. It operates on a B2B and Service-based Consulting model. Its Indian entity Intergene Biosciences Private Limited reported revenue of β‚Ή8.2 Lakh. Intergene Biosciences offers products and services including Fungal ITS2 Amplicon Sequencing, Bacterial 16S rRNA Sequencing, ddRAD Library Preparation, Fungal Genome Sequencing, and Bacterial Genome Sequencing. Its focus areas include Life Sciences, Biotechnology, Genomics and Sequencing Services.

Company details

Intergene Biosciences is a technology-driven company based in Bangalore, India, focusing on genetic research and development. They deliver services such as DNA sequencing, metabolomics analysis, and training to industries, life science professionals, and students. Through RD support, they enable advancements in genomics and related fields, serving clients in biotechnology and education sectors with specialized tools and expertise.

  • Headquarters Bengaluru, India
  • Employees 1
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website intergenebio.com
  • Legal Name Intergene Biosciences Pvt Ltd
  • Date of Incorporation 06 Apr, 2021
  • Jurisdiction Bangalore, Karnataka, India
Key Metrics
  • Annual Revenue
    ₹8.2 Lakh

    FY 2025 · +55% YoY

  • Net Loss
    -₹3.9 Lakh

    FY 2025 · -48% margin

  • EBITDA
    -₹4.6 Lakh

    FY 2025 · -56% margin

  • Employee Count
    1

Products & Services of Intergene Biosciences

Intergene Biosciences offers a comprehensive portfolio of products and services, including Fungal ITS2 Amplicon Sequencing, Bacterial 16S rRNA Sequencing, ddRAD Library Preparation, Fungal Genome Sequencing, and Bacterial Genome Sequencing.

Fungal ITS2 Amplicon Sequencing
Sequencing Service

Analysis of fungal DNA for species identification and research.

Bacterial 16S rRNA Sequencing
Sequencing Service

Sequencing for bacterial diversity and identification studies.

ddRAD Library Preparation
Genomic Service

Preparation of libraries for reduced representation genome sequencing.

Fungal Genome Sequencing
Sequencing Service

Full genome sequencing and analysis for fungal organisms.

Bacterial Genome Sequencing
Sequencing Service

Sequencing and analysis of bacterial genomes for research.

Aptamer Sequencing and Analysis
Molecular Service

Sequencing of aptamers for targeted applications in biology.

ChIP Sequencing and Analysis
Epigenomic Service

Analysis of protein-DNA interactions through sequencing.

Mitochondrial Genome Sequencing
Sequencing Service

Sequencing and analysis of mitochondrial DNA.

Human Exome Sequencing
Genomic Service

Sequencing of human exomes for variant detection.

Rice Genome Sequencing
Agricultural Genomics

Sequencing and variant calling for rice genomes.

Metabolomics Analysis
Biochemical Service

Comprehensive analysis of metabolites in biological samples.

Board of directors of Intergene Biosciences Private Limited (Intergene Biosciences)

Intergene Biosciences Private Limited is the primary company behind Intergene Biosciences. The board of Intergene Biosciences Private Limited currently have 3 directors; the longest-serving is Ganessin Aravind, appointed in 2021.

DirectorDesignationAppointedTenureEntity
Ganessin Aravind
DIN 07951693
Director06 Apr 20215 yrs 6 moIntergene Biosciences Private Limited
Uma Thiagarajan
DIN 09134661
Director06 Apr 20215 yrs 6 moIntergene Biosciences Private Limited
Aniruddha Maram
DIN 10597809
Director25 Apr 20242 yrs 6 moIntergene Biosciences Private Limited

Financials of Intergene Biosciences

Figures of Intergene Biosciences Private Limited, the primary company behind Intergene Biosciences, for FY 2025. Revenue was ₹8.2 Lakh (+55% year on year). Net loss was -₹3.9 Lakh (-48% margin). EBITDA was -₹4.6 Lakh (-56% margin). Revenue has grown at a compounded annual rate of +90% over three years.

  • ₹8.2 LakhRevenue · FY 2025 · +55% YoY
  • -₹3.9 LakhNet loss · -48% margin
  • -₹4.6 LakhEBITDA · -56% margin
  • ₹1 LakhPaid-up capital
  • +90%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Intergene Biosciences Private Limited are on its company page.

Premium access

Detailed financial statements for Intergene Biosciences

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Intergene Biosciences

Intergene Biosciences was founded in 2021.

Intergene Biosciences is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Intergene Biosciences has 1 employees.

The primary company behind Intergene Biosciences, Intergene Biosciences Private Limited, reported revenue of β‚Ή8.2 Lakh for FY 2025, up 55% year on year.

Intergene Biosciences is a technology-driven company based in Bangalore, India, focusing on genetic research and development. They deliver services such as DNA sequencing, metabolomics analysis, and training to industries, life science professionals, and students. Through RD support, they enable advancements in genomics and related fields, serving clients in biotechnology and education sectors with specialized tools and expertise.

Intergene Biosciences offers Fungal ITS2 Amplicon Sequencing, Bacterial 16S rRNA Sequencing, ddRAD Library Preparation, Fungal Genome Sequencing, and 6 more products and services.

Intergene Biosciences operates through Intergene Biosciences Private Limited.

The legal entities of Intergene Biosciences currently have 3 directors, including Ganessin Aravind, Uma Thiagarajan, Aniruddha Maram.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available